AUTL
Autolus Therapeutics
AUTL
AUTL
95 hedge funds and large institutions have $234M invested in Autolus Therapeutics in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less ownership
Funds ownership: 62.35% → 54.35% (-8%)
38% less capital invested
Capital invested by funds: $378M → $234M (-$145M)
Holders
95
Holding in Top 10
3
Calls
$488K
Puts
$98K
Top Buyers
| 1 | +$14.8M | |
| 2 | +$8.21M | |
| 3 | +$7.67M | |
| 4 |
AC
Armistice Capital
New York
|
+$5.87M |
| 5 |
Renaissance Technologies
New York
|
+$5.1M |
Top Sellers
| 1 | -$61.9M | |
| 2 | -$23.3M | |
| 3 | -$16.2M | |
| 4 |
Axa
Paris,
France
|
-$7.13M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.14M |
